Related Experiment Video
Updated: May 23, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c
Asami Hagiwara1, Marion Cornu, Nadine Cybulski
1Biozentrum, University of Basel, CH-4056 Basel, Switzerland.
Abstract:
Mammalian target of rapamycin complex 2 (mTORC2) phosphorylates and activates AGC kinase family members, including Akt, SGK1, and PKC, in response to insulin/IGF1. The liver is a key organ in insulin-mediated regulation of metabolism. To assess the role of hepatic mTORC2, we generated liver-specific rictor knockout (LiRiKO) mice. Fed LiRiKO mice displayed loss of Akt Ser473 phosphorylation and reduced glucokinase and SREBP1c activity in the liver, leading to constitutive gluconeogenesis, and impaired glycolysis and lipogenesis, suggesting that the mTORC2-deficient liver is unable to sense satiety. These liver-specific defects resulted in systemic hyperglycemia, hyperinsulinemia, and hypolipidemia. Expression of constitutively active Akt2 in mTORC2-deficient hepatocytes restored both glucose flux and lipogenesis, whereas glucokinase overexpression rescued glucose flux but not lipogenesis. Thus, mTORC2 regulates hepatic glucose and lipid metabolism via insulin-induced Akt signaling to control whole-body metabolic homeostasis. These findings have implications for emerging drug therapies that target mTORC2.
Insights
Mammalian target of rapamycin complex 2 (mTORC2) regulates liver metabolism by activating Akt signaling. Liver-specific mTORC2 deficiency causes hyperglycemia and hypolipidemia, impacting whole-body metabolic homeostasis.
Area of Science:
- Biochemistry
- Metabolic Regulation
- Cell Signaling
Background:
- Mammalian target of rapamycin complex 2 (mTORC2) is crucial for cell growth and survival.
- mTORC2 phosphorylates AGC kinases like Akt, SGK1, and PKC in response to insulin/IGF1.
- The liver plays a central role in insulin-mediated metabolic control.
Purpose of the Study:
- To investigate the specific role of hepatic mTORC2 in regulating liver metabolism.
- To understand the downstream signaling pathways affected by hepatic mTORC2.
- To determine the impact of liver-specific mTORC2 deficiency on systemic metabolic homeostasis.
Main Methods:
- Generation of liver-specific rictor knockout (LiRiKO) mice.
- Analysis of hepatic Akt phosphorylation, glucokinase, and SREBP1c activity.
- Assessment of glucose and lipid metabolism in LiRiKO mice and hepatocytes.
Main Results:
- LiRiKO mice exhibited loss of Akt Ser473 phosphorylation in the liver.
- Hepatic mTORC2 deficiency led to constitutive gluconeogenesis and impaired glycolysis/lipogenesis.
- Systemic effects included hyperglycemia, hyperinsulinemia, and hypolipidemia.
- Restoration of Akt2 or glucokinase activity in deficient hepatocytes partially rescued metabolic defects.
Conclusions:
- Hepatic mTORC2 is essential for regulating glucose and lipid metabolism through insulin-induced Akt signaling.
- mTORC2-deficient livers are unable to sense satiety, leading to metabolic dysregulation.
- These findings highlight mTORC2 as a potential therapeutic target for metabolic disorders.
More Related Videos
08:03Live-Cell Förster Resonance Energy Transfer Imaging of Metabolically Regulated Akt Activation Dynamics in HepG2 Cells
Published on: May 23, 2025
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
cAMP-dependent Protein Kinase Pathways
MAPK Signaling Cascades
Regulation of Metabolism